Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The purpose of this study was to see if adding a new type of medication recently approved to treat overactive bladder (mirabegron) to an antimuscarinic treatment (solifenacin) would be more effective in controlling incontinence than when using the antimuscarinic treatment alone.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Main Inclusion at Screening:
Main Inclusion at Run-in (Visit 2):
Main Inclusion at Randomization (Visit 3):
Exclusion criteria
Main Exclusion at Screening:
Main Exclusion at Randomization (visit 3):
Primary purpose
Allocation
Interventional model
Masking
2,174 participants in 3 patient groups
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal